The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
Flutamide (CAS 13311-84-7), C11H11F3N2O3, the formula weight is 276.21, and its form is yellow powder.
The global Flutamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Flutamide is used for prostate cancer or benign prostatic hypertrophy. This product can be combined with leucolide to treat metastatic prostate cancer, which can significantly increase the efficacy.
This report aims to provide a comprehensive presentation of the global market for Flutamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flutamide.
Report Scope
The Flutamide market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flutamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flutamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Forward
Merck
Tasly Diyi Pharma
Cipla LifeScience
Actiza Pharma
TEVA Pharma
Florencia Healthcare
SANDOZ
Segment by Type
Flutamide Tablets
Flutamide Capsule
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flutamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Flutamide (CAS 13311-84-7), C11H11F3N2O3, the formula weight is 276.21, and its form is yellow powder.
The global Flutamide market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Flutamide is used for prostate cancer or benign prostatic hypertrophy. This product can be combined with leucolide to treat metastatic prostate cancer, which can significantly increase the efficacy.
This report aims to provide a comprehensive presentation of the global market for Flutamide, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Flutamide.
Report Scope
The Flutamide market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Flutamide market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Flutamide manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Forward
Merck
Tasly Diyi Pharma
Cipla LifeScience
Actiza Pharma
TEVA Pharma
Florencia Healthcare
SANDOZ
Segment by Type
Flutamide Tablets
Flutamide Capsule
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Flutamide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Flutamide in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Flutamide Market Overview
1.1 Product Overview and Scope of Flutamide
1.2 Flutamide Segment by Type
1.2.1 Global Flutamide Market Value Comparison by Type (2024-2030)
1.2.2 Flutamide Tablets
1.2.3 Flutamide Capsule
1.2.4 Others
1.3 Flutamide Segment by Application
1.3.1 Global Flutamide Market Value by Application: (2024-2030)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Flutamide Market Size Estimates and Forecasts
1.4.1 Global Flutamide Revenue 2019-2030
1.4.2 Global Flutamide Sales 2019-2030
1.4.3 Global Flutamide Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Flutamide Market Competition by Manufacturers
2.1 Global Flutamide Sales Market Share by Manufacturers (2019-2024)
2.2 Global Flutamide Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Flutamide Average Price by Manufacturers (2019-2024)
2.4 Global Flutamide Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Flutamide, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Flutamide, Product Type & Application
2.7 Flutamide Market Competitive Situation and Trends
2.7.1 Flutamide Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Flutamide Players Market Share by Revenue
2.7.3 Global Flutamide Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Flutamide Retrospective Market Scenario by Region
3.1 Global Flutamide Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Flutamide Global Flutamide Sales by Region: 2019-2030
3.2.1 Global Flutamide Sales by Region: 2019-2024
3.2.2 Global Flutamide Sales by Region: 2025-2030
3.3 Global Flutamide Global Flutamide Revenue by Region: 2019-2030
3.3.1 Global Flutamide Revenue by Region: 2019-2024
3.3.2 Global Flutamide Revenue by Region: 2025-2030
3.4 North America Flutamide Market Facts & Figures by Country
3.4.1 North America Flutamide Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Flutamide Sales by Country (2019-2030)
3.4.3 North America Flutamide Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Flutamide Market Facts & Figures by Country
3.5.1 Europe Flutamide Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Flutamide Sales by Country (2019-2030)
3.5.3 Europe Flutamide Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Flutamide Market Facts & Figures by Country
3.6.1 Asia Pacific Flutamide Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Flutamide Sales by Country (2019-2030)
3.6.3 Asia Pacific Flutamide Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Flutamide Market Facts & Figures by Country
3.7.1 Latin America Flutamide Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Flutamide Sales by Country (2019-2030)
3.7.3 Latin America Flutamide Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Flutamide Market Facts & Figures by Country
3.8.1 Middle East and Africa Flutamide Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Flutamide Sales by Country (2019-2030)
3.8.3 Middle East and Africa Flutamide Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Flutamide Sales by Type (2019-2030)
4.1.1 Global Flutamide Sales by Type (2019-2024)
4.1.2 Global Flutamide Sales by Type (2025-2030)
4.1.3 Global Flutamide Sales Market Share by Type (2019-2030)
4.2 Global Flutamide Revenue by Type (2019-2030)
4.2.1 Global Flutamide Revenue by Type (2019-2024)
4.2.2 Global Flutamide Revenue by Type (2025-2030)
4.2.3 Global Flutamide Revenue Market Share by Type (2019-2030)
4.3 Global Flutamide Price by Type (2019-2030)
5 Segment by Application
5.1 Global Flutamide Sales by Application (2019-2030)
5.1.1 Global Flutamide Sales by Application (2019-2024)
5.1.2 Global Flutamide Sales by Application (2025-2030)
5.1.3 Global Flutamide Sales Market Share by Application (2019-2030)
5.2 Global Flutamide Revenue by Application (2019-2030)
5.2.1 Global Flutamide Revenue by Application (2019-2024)
5.2.2 Global Flutamide Revenue by Application (2025-2030)
5.2.3 Global Flutamide Revenue Market Share by Application (2019-2030)
5.3 Global Flutamide Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Forward
6.1.1 Forward Corporation Information
6.1.2 Forward Description and Business Overview
6.1.3 Forward Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Forward Flutamide Product Portfolio
6.1.5 Forward Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Flutamide Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Tasly Diyi Pharma
6.3.1 Tasly Diyi Pharma Corporation Information
6.3.2 Tasly Diyi Pharma Description and Business Overview
6.3.3 Tasly Diyi Pharma Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Tasly Diyi Pharma Flutamide Product Portfolio
6.3.5 Tasly Diyi Pharma Recent Developments/Updates
6.4 Cipla LifeScience
6.4.1 Cipla LifeScience Corporation Information
6.4.2 Cipla LifeScience Description and Business Overview
6.4.3 Cipla LifeScience Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla LifeScience Flutamide Product Portfolio
6.4.5 Cipla LifeScience Recent Developments/Updates
6.5 Actiza Pharma
6.5.1 Actiza Pharma Corporation Information
6.5.2 Actiza Pharma Description and Business Overview
6.5.3 Actiza Pharma Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Actiza Pharma Flutamide Product Portfolio
6.5.5 Actiza Pharma Recent Developments/Updates
6.6 TEVA Pharma
6.6.1 TEVA Pharma Corporation Information
6.6.2 TEVA Pharma Description and Business Overview
6.6.3 TEVA Pharma Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.6.4 TEVA Pharma Flutamide Product Portfolio
6.6.5 TEVA Pharma Recent Developments/Updates
6.7 Florencia Healthcare
6.6.1 Florencia Healthcare Corporation Information
6.6.2 Florencia Healthcare Description and Business Overview
6.6.3 Florencia Healthcare Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Florencia Healthcare Flutamide Product Portfolio
6.7.5 Florencia Healthcare Recent Developments/Updates
6.8 SANDOZ
6.8.1 SANDOZ Corporation Information
6.8.2 SANDOZ Description and Business Overview
6.8.3 SANDOZ Flutamide Sales, Revenue and Gross Margin (2019-2024)
6.8.4 SANDOZ Flutamide Product Portfolio
6.8.5 SANDOZ Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Flutamide Industry Chain Analysis
7.2 Flutamide Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Flutamide Production Mode & Process
7.4 Flutamide Sales and Marketing
7.4.1 Flutamide Sales Channels
7.4.2 Flutamide Distributors
7.5 Flutamide Customers
8 Flutamide Market Dynamics
8.1 Flutamide Industry Trends
8.2 Flutamide Market Drivers
8.3 Flutamide Market Challenges
8.4 Flutamide Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
